Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation

AJ Kombe Kombe, B Li, A Zahid, HM Mengist… - Frontiers in public …, 2021 - frontiersin.org
Diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women,
human papillomavirus (HPV) is currently the most common pathogen responsible for female …

Cervical cancer immunotherapy: facts and hopes

L Ferrall, KY Lin, RBS Roden, CF Hung, TC Wu - Clinical Cancer Research, 2021 - AACR
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …

[HTML][HTML] Cervical cancer in low and middle‑income countries

R Hull, M Mbele, T Makhafola, C Hicks… - Oncology …, 2020 - spandidos-publications.com
Cervical cancer is a malignant tumour that occurs in the cervix and is classified into two
histological types, adenocarcinoma and squamous cell carcinoma (SCC); SCC is more …

[HTML][HTML] Cancer cervix: Epidemiology and disease burden

S Pimple, G Mishra - Cytojournal, 2022 - ncbi.nlm.nih.gov
Cervical cancer remains a major public health problem, ranking as the fourth most common
cause of cancer incidence and mortality in women worldwide. Wide variations in cervical …

Global cancer in women: burden and trends

LA Torre, F Islami, RL Siegel, EM Ward… - … , biomarkers & prevention, 2017 - AACR
This review is an abbreviated version of a report prepared for the American Cancer Society
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …

Cancer statistics in China, 2015

W Chen, R Zheng, PD Baade, S Zhang… - CA: a cancer journal …, 2016 - Wiley Online Library
With increasing incidence and mortality, cancer is the leading cause of death in China and is
a major public health problem. Because of China's massive population (1.37 billion) …

Approved antiviral drugs over the past 50 years

E De Clercq, G Li - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …

Global cancer incidence and mortality rates and trends—an update

LA Torre, RL Siegel, EM Ward, A Jemal - Cancer epidemiology, biomarkers & …, 2016 - AACR
There are limited published data on recent cancer incidence and mortality trends worldwide.
We used the International Agency for Research on Cancer's CANCER Mondial …

Epidemiology and burden of HPV-related disease

B Serrano, M Brotons, FX Bosch, L Bruni - Best practice & research Clinical …, 2018 - Elsevier
Human papillomavirus (HPV) infection is recognized as one of the major causes of infection-
related cancer in both men and women. High-risk HPV types are not only responsible for …

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

WK Huh, EA Joura, AR Giuliano, OE Iversen… - The Lancet, 2017 - thelancet.com
Background Primary analyses of a study in young women aged 16–26 years showed
efficacy of the nine-valent human papillomavirus (9vHPV; HPV 6, 11, 16, 18, 31, 33, 45, 52 …